Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction

Immunological Reviews

Volumn 267, Issue 1, 2015, Pages 283-297

  Moffett, Ashley ^a   Colucci, Francesco ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Birth weight; HLA; KIR; Placenta; Trophoblast

Indexed keywords

HLA ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; NATURAL KILLER CELL RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND;

ALLELE; ARTICLE; DECIDUA; EVOLUTION; GENETIC ASSOCIATION; HAPLOTYPE; HIGH BIRTH WEIGHT; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE; LOW BIRTH WEIGHT; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NEWBORN DEATH; PATHOGENESIS; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PRIORITY JOURNAL; TROPHOBLAST; FEMALE; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; PREGNANCY;

EVOLUTION, MOLECULAR; FEMALE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTORS, KIR; TROPHOBLASTS;

EID: 84939529783     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12323     Document Type: Article

References (99)

1. Brown D. Washington post, 2013. http://www.washingtonpost.com/national/health-science/lady-sybils-shocking-death/2013/01/28/c0f41e14-697a-11e2-ada3-d86a4806d5ee_story.html
2. Lyall F, Belfort MA eds. Pre-eclampsia: Etiology and Clinical Practice. Cambridge, UK: Cambridge University Press, 2007.
3. Nakimuli A, et al. Pregnancy, parturition and preeclampsia in women of African ancestry. Am J Obstet Gynecol 2014;210:510-520 e511.
4. Goulopoulou S, Davidge ST. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med 2015;21:88-97.
5. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The, "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
6. Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008;61:1243-1246.
7. Wittman AB, Wall LL. The evolutionary origins of obstructed labor: bipedalism, encephalization, and the human obstetric dilemma. Obstet Gynecol Surv 2007;62:739-748.
8. Fischer B, Mitteroecker P. Covariation between human pelvis shape, stature, and head size alleviates the obstetric dilemma. Proc Natl Acad Sci USA 2015;112:5655-5660.
9. Gruss LT, Schmitt D. The evolution of the human pelvis: changing adaptations to bipedalism, obstetrics and thermoregulation. Philos Trans R Soc Lond B Biol Sci 2015;370:20140063.
10. Trevathan W. Primate pelvic anatomy and implications for birth. Philos Trans R Soc Lond B Biol Sci 2015;370:20140065.
11. Cavalli-Sforza LL, Bodmer WF. The Genetics of Human Populations. San Francisco: W.H. Freeman and Company, 1971.
12. Hiby SE, et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J Immunol 2014;192:5069-5073.
13. Moraitis AA, Wood AM, Fleming M, Smith GC. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol 2014;124:274-283.
14. Marti JJ, Herrmann U. Immunogestosis: a new etiologic concept of "essential" EPH gestosis, with special consideration of the primigravid patient; preliminary report of a clinical study. Am J Obstet Gynecol 1977;128:489-493.
15. Dekker G, Robillard PY. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod Immunol 2007;76:8-16.
16. Klungsoyr K, Morken NH, Irgens L, Vollset SE, Skjaerven R. Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival. Paediatr Perinat Epidemiol 2012;26:190-198.
17. Hickey M, Higham JM, Fraser I. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syt Rev 2012;9:CD001895.
18. Shachar BZ, Lyell DJ. Interpregnancy interval and obstetrical complications. Obstet Gynecol Surv 2012;67:584-596.
19. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004;130A:365-371.
20. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Sym Soc Exp Biol 1953;7:320-338.
21. Colucci F, Kieckbusch J. Maternal uterine natural killer cells nurture fetal growth: in medio stat virtus. Trends Mol Med 2015;21:60-67.
22. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest 2014;124:1872-1879.
23. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991;6:791-798.
24. Ferry BL, Sargent IL, Starkey PM, Redman CW. Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy decidua. Cell Immunol 1991;132:140-149.
25. King A, Loke YW. On the nature and function of human uterine granular lymphocytes. Immunol Today 1991;12:432-435.
26. Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 2010;31(Suppl):S87-S92.
27. Gundling WE Jr, Wildman DE. A review of inter- and intraspecific variation in the eutherian placenta. Philos Trans R Soc Lond B Biol Sci 2015;370:20140072.
28. Moretta L, et al. Human NK cells: from surface receptors to the therapy of leukemias and solid tumors. Front Immunol 2014;5:87.
29. Apps R, et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009;127:26-39.
30. Apps R, Gardner L, Hiby SE, Sharkey AM, Moffett A. Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology 2008;124:322-328.
31. Apps R, Gardner L, Traherne J, Male V, Moffett A. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum Reprod 2008;23:2535-2548.
32. Hanna J, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006;12:1065-1074.
33. Mincheva-Nilsson L, et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol 2006;176:3585-3592.
34. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 2013;13:133-144.
35. Hiby SE, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010;120:4102-4110.
36. Fuchs EJ, Huang XJ, Miller JS. HLA-haploidentical stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2010;16:S57-S63.
37. Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-2100.
38. IPD-KIR - European Bioinformatics Institute. http://www.ebi.ac.uk/ipd/kir/.
39. Jiang W, et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012;22:1845-1854.
40. Pyo CW, et al. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS ONE 2010;5:e15115.
41. Beziat V, et al. Influence of KIR gene copy number on natural killer cell education. Blood 2013;121:4703-4707.
42. Hiby SE, et al. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008;23:972-976.
43. Hiby SE, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
44. Nakimuli A, et al. A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc Natl Acad Sci USA 2015;112:845-850.
45. Xiong S, et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest 2013;123:4264-4272.
46. Hilton HG, et al. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol 2012;189:1418-1430.
47. Cooley S, et al. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J Immunol 2014;192:4592-4600.
48. Mancusi A, et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood 2015;125:3173-3182.
49. Chan HW, et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med 2003;197:245-255.
50. Wilkens J, et al. Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J Immunol 2013;191:2226-2235.
51. Male V, et al. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010;185:3913-3918.
52. Horowitz A, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 2013;5:208ra145.
53. Male V, et al. The effect of pregnancy on the uterine NK cell KIR repertoire. Eur J Immunol 2011;41:3017-3027.
54. Sharkey AM, et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol 2008;181:39-46.
55. Sleiman M, et al. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules. J Immunol 2014;192:2602-2610.
56. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007;37:1924-1937.
57. Allan DS, et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999;189:1149-1156.
58. Shiroishi M, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006;281:10439-10447.
59. Shiroishi M, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 2006;103:16412-16417.
60. Boyson JE, et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002;99:16180-16185.
61. Clements CS, et al. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 2005;102:3360-3365.
62. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008;29:313-321.
63. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005;35:1133-1142.
64. +dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci USA 2012;109:18885-18890.
65. Bashirova AA, et al. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS Genet 2014;10:e1004196.
66. King A, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000;30:1623-1631.
67. Llano M, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998;28:2854-2863.
68. Petrie EJ, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 2008;205:725-735.
69. Beziat V, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013;121:2678-2688.
70. Goodier MR, et al. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 2014;124:2213-2222.
71. Heatley SL, et al. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem 2013;288:8679-8690.
72. Rajagopalan S, Long EO. KIR2DL4 (CD158d): an activation receptor for HLA-G. Front Immunol 2012;3:258.
73. Moradi S, et al. The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4. J Biol Chem 2015;290:10460-10471.
74. Brusilovsky M, et al. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses. J Immunol 2013;191:5256-5267.
75. Chakraborty D, Rumi MA, Konno T, Soares MJ. Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions. Proc Natl Acad Sci USA 2011;108:16295-16300.
76. Madeja Z, et al. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci USA 2011;108:4012-4017.
77. Kieckbusch J, Gaynor LM, Moffett A, Colucci F. MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling. Nat Commun 2014;5:3359.
78. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 2012;367:800-811.
79. WHO. Trends in maternal mortality: 1990 to 2013. http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2013/en/
80. Carter AM, Enders AC, Pijnenborg R. The role of invasive trophoblast in implantation and placentation of primates. Philos Trans R Soc Lond B Biol Sci 2015;370:20140070.
81. Adams EJ, Thomson G, Parham P. Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus. Immunogenetics 1999;49:865-871.
82. Older Aguilar AM, et al. Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells. J Immunol 2010;185:4238-4251.
83. Abi-Rached L, Moesta AK, Rajalingam R, Guethlein LA, Parham P. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet 2010;6:e1001192.
84. Abi-Rached L, et al. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 2011;334:89-94.
85. Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Vaccines. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015;348:694-699.
86. Civetta A. Adaptive evolution at immune system genes and deep pregnancy implantation in primates. Genomics 2015;105:17-22.
87. Grimwood J, et al. The DNA sequence and biology of human chromosome 19. Nature 2004;428:529-535.
88. Apps R, et al. Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells. Placenta 2011;32:33-43.
89. Founds SA, et al. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009;30:15-24.
90. Moore T, Dveksler GS. Pregnancy-specific glycoproteins: complex gene families regulating maternal-fetal interactions. Int J Dev Biol 2014;58:273-280.
91. Pyzik M, Rath T, Lencer WI, Baker K, Blumberg RS. FcRn: the architect behind the immune and nonimmune functions of IgG and albumin. J Immunol 2015;194:4595-4603.
92. Dixon PH, et al. Mutations in NLRP7 are associated with diploid biparental hydatidiform moles, but not androgenetic complete moles. J Med Genet 2012;49:206-211.
93. Valdes G, Corthorn J. Review: the angiogenic and vasodilatory utero-placental network. Placenta 2011;32(Suppl 2):S170-S175.
94. Kupka MS, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHREdagger. Hum Reprod 2014;29:2099-2113.
95. Thomopoulos C, et al. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens 2013;27:148-157.
96. Opdahl S, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod 2015;30:1724-1731.
97. Alecsandru D, et al. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod 2014;29:2637-2643.
98. Gendzekhadze K, et al. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci USA 2009;106:18692-18697.
99. Hublin JJ, Neubauer S, Gunz P. Brain ontogeny and life history in Pleistocene hominins. Philos Trans R Soc Lond B Biol Sci 2015;370:20140062.